2023 Q3 Form 10-Q Financial Statement

#000149315223029420 Filed on August 18, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $1.644M $706.7K $1.082M
YoY Change -60.78% -34.7% -26.84%
Cost Of Revenue $944.5K $475.3K $828.1K
YoY Change -69.18% -42.6% -33.06%
Gross Profit $699.6K $231.4K $254.1K
YoY Change -37.96% -8.95% 4.95%
Gross Profit Margin 42.55% 32.74% 23.48%
Selling, General & Admin $154.9K $242.6K $192.1K
YoY Change -56.91% 26.31% 3.78%
% of Gross Profit 22.15% 104.86% 75.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.575K $1.575K $1.698K
YoY Change 503.45% -7.24% 0.53%
% of Gross Profit 0.23% 0.68% 0.67%
Operating Expenses $156.5K $244.2K $193.8K
YoY Change -56.5% 26.01% 3.75%
Operating Profit $543.1K -$12.81K $60.34K
YoY Change -29.28% -121.23% 8.97%
Interest Expense $20.12K $25.45K $31.33K
YoY Change -26.19% -18.77% 161.08%
% of Operating Profit 3.7% 51.92%
Other Income/Expense, Net -$20.12K -$25.45K -$31.33K
YoY Change -183.5% -18.77% 161.08%
Pretax Income $523.0K -$38.26K $29.01K
YoY Change -33.97% -231.87% -33.11%
Income Tax
% Of Pretax Income
Net Earnings $523.0K -$38.26K $29.01K
YoY Change -33.97% -231.87% -33.11%
Net Earnings / Revenue 31.81% -5.41% 2.68%
Basic Earnings Per Share $0.01 $0.00 $0.00
Diluted Earnings Per Share $0.01 $0.00 $809.80
COMMON SHARES
Basic Shares Outstanding 40.41M shares 35.82M shares 35.82M shares
Diluted Shares Outstanding 40.41M shares 39.19M shares 35.82M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.08K $17.68K $121.8K
YoY Change -86.89% -85.49% -62.04%
Cash & Equivalents $56.08K $17.68K $121.8K
Short-Term Investments
Other Short-Term Assets $610.8K $398.3K $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables $178.1K $127.8K $318.9K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.003M $654.9K $1.072M
YoY Change -37.61% -38.92% 4.53%
LONG-TERM ASSETS
Property, Plant & Equipment $1.491K $3.066K $19.72K
YoY Change -95.44% -84.45% -4.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.545M $7.161M $7.881M
YoY Change 51.07% -9.13% 21.56%
Total Long-Term Assets $9.546M $7.164M $7.932M
YoY Change 49.56% -9.69% 21.38%
TOTAL ASSETS
Total Short-Term Assets $1.003M $654.9K $1.072M
Total Long-Term Assets $9.546M $7.164M $7.932M
Total Assets $10.55M $7.819M $9.005M
YoY Change 32.02% -13.17% 19.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $846.4K $945.8K $463.2K
YoY Change 21.7% 104.21% -6.61%
Accrued Expenses $328.5K $287.1K $173.1K
YoY Change 63.95% 65.88% 402.58%
Deferred Revenue $55.61K $93.00K $333.4K
YoY Change -71.66% -72.1%
Short-Term Debt $1.256M $2.747M $3.894M
YoY Change -37.47% -29.45% 9.15%
Long-Term Debt Due $922.0K $923.7K $911.2K
YoY Change 1.46% 1.37% 2.02%
Total Short-Term Liabilities $3.419M $5.007M $5.791M
YoY Change -22.91% -13.54% 9.41%
LONG-TERM LIABILITIES
Long-Term Debt $5.815M $2.019M $2.534M
YoY Change 178.95% -20.34% 46.93%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.815M $2.019M $2.534M
YoY Change 178.95% -20.34% 46.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.419M $5.007M $5.791M
Total Long-Term Liabilities $5.815M $2.019M $2.534M
Total Liabilities $9.234M $7.026M $8.326M
YoY Change 41.63% -15.61% 18.63%
SHAREHOLDERS EQUITY
Retained Earnings -$1.052M -$1.575M -$1.597M
YoY Change 30.69% -1.38%
Common Stock $40.41K $40.41K $35.82K
YoY Change 12.81% 12.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.316M $792.8K $679.0K
YoY Change
Total Liabilities & Shareholders Equity $10.55M $7.819M $9.005M
YoY Change 32.02% -13.17% 19.09%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $523.0K -$38.26K $29.01K
YoY Change -33.97% -231.87% -33.11%
Depreciation, Depletion And Amortization $1.575K $1.575K $1.698K
YoY Change 503.45% -7.24% 0.53%
Cash From Operating Activities $117.0K $447.1K -$91.27K
YoY Change -82.94% -589.88% -154.29%
INVESTING ACTIVITIES
Capital Expenditures $2.384M $671.7K -$83.96K
YoY Change 299.84% -899.99%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.384M -$671.7K -$83.96K
YoY Change -499.84% 699.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.297M 51.12K 169.6K
YoY Change -335.46% -69.85% -185.91%
NET CHANGE
Cash From Operating Activities 117.0K 447.1K -91.27K
Cash From Investing Activities -2.384M -671.7K -83.96K
Cash From Financing Activities 2.297M 51.12K 169.6K
Net Change In Cash 30.68K -173.4K -5.660K
YoY Change -89.97% 2964.31% -80.64%
FREE CASH FLOW
Cash From Operating Activities $117.0K $447.1K -$91.27K
Capital Expenditures $2.384M $671.7K -$83.96K
Free Cash Flow -$2.267M -$224.6K -$7.310K
YoY Change -2638.05% 2971.96% -104.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001518336
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Increase Decrease In Due From Employee Current
IncreaseDecreaseInDueFromEmployeeCurrent
usd
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
usd
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity File Number
EntityFileNumber
000-55445
dei Entity Registrant Name
EntityRegistrantName
DREAM HOMES & DEVELOPMENT CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2208821
dei Entity Address Address Line1
EntityAddressAddressLine1
314 South Main Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Forked River
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08731
dei City Area Code
CityAreaCode
609
dei Local Phone Number
LocalPhoneNumber
693 8881
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40414493 shares
CY2023Q2 us-gaap Cash
Cash
17679 usd
CY2022Q4 us-gaap Cash
Cash
525389 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
127848 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
213008 usd
CY2023Q2 DREM Prepaid Feesproperty Held For Development Current
PrepaidFeespropertyHeldForDevelopmentCurrent
398304 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
111089 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
256558 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
654920 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
994955 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3066 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6216 usd
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2200 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2200 usd
CY2023Q2 DREM Deposits And Costs Coincident To Acquisition Of Land For Development
DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment
7158634 usd
CY2022Q4 DREM Deposits And Costs Coincident To Acquisition Of Land For Development
DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment
6179085 usd
CY2023Q2 us-gaap Assets
Assets
7818820 usd
CY2022Q4 us-gaap Assets
Assets
7182456 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
945818 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
644913 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
287133 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
227308 usd
CY2023Q2 us-gaap Deposit Liability Current
DepositLiabilityCurrent
10000 usd
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
10000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
92997 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
256757 usd
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
923660 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
908660 usd
CY2023Q2 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
1388563 usd
CY2022Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
3113563 usd
CY2023Q2 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
369178 usd
CY2022Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
492500 usd
CY2023Q2 us-gaap Other Notes Payable
OtherNotesPayable
552833 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5007002 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5908596 usd
CY2023Q2 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
2019016 usd
CY2022Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
635016 usd
CY2023Q2 us-gaap Liabilities
Liabilities
7026018 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6543612 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40414493 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35824493 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
40414 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
35824 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2327330 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2240120 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1574942 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1637100 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
792802 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
638844 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7818820 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7182456 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
706669 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1082202 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
475304 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
828090 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
231365 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
254112 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
91800 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
242598 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
192071 usd
CY2023Q2 us-gaap Depreciation
Depreciation
1575 usd
CY2022Q2 us-gaap Depreciation
Depreciation
1698 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
244173 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
193769 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12808 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
60343 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
25450 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
31330 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25450 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31330 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38258 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29013 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38258 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
29013 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39190495 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39190495 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35824493 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35824493 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1811135 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2077407 usd
us-gaap Cost Of Revenue
CostOfRevenue
1126748 usd
us-gaap Cost Of Revenue
CostOfRevenue
1412956 usd
us-gaap Gross Profit
GrossProfit
684387 usd
us-gaap Gross Profit
GrossProfit
664451 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
91800 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
538032 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
408093 usd
us-gaap Depreciation
Depreciation
3150 usd
us-gaap Depreciation
Depreciation
3387 usd
us-gaap Operating Expenses
OperatingExpenses
541182 usd
us-gaap Operating Expenses
OperatingExpenses
411480 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
143205 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
252971 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
143205 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
252971 usd
us-gaap Interest Expense
InterestExpense
81047 usd
us-gaap Interest Expense
InterestExpense
58752 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-81047 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-58752 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
62158 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
194219 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
62158 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
194219 usd
us-gaap Net Income Loss
NetIncomeLoss
62158 usd
us-gaap Net Income Loss
NetIncomeLoss
194219 usd
us-gaap Net Income Loss
NetIncomeLoss
62158 usd
us-gaap Net Income Loss
NetIncomeLoss
194219 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37507493 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37507493 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35824493 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35824493 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
484754 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
165206 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
649960 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
29013 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
678973 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
638844 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
100416 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
739260 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
739260 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4590000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
91800 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38258 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38258 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
792802 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
792802 usd
us-gaap Net Income Loss
NetIncomeLoss
62158 usd
us-gaap Net Income Loss
NetIncomeLoss
194219 usd
us-gaap Depreciation
Depreciation
3150 usd
us-gaap Depreciation
Depreciation
3387 usd
us-gaap Share Based Compensation
ShareBasedCompensation
91800 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-85160 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-38502 usd
us-gaap Increase Decrease In Due From Employee Current
IncreaseDecreaseInDueFromEmployeeCurrent
-2705 usd
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
398304 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-145469 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
372898 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
300905 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
120485 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
59828 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
53015 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-163760 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-80203 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
186406 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40788 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
5790 usd
us-gaap Payments To Acquire Land
PaymentsToAcquireLand
979549 usd
us-gaap Payments To Acquire Land
PaymentsToAcquireLand
609391 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-979549 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-615181 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
15000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-18572 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1350000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1725000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
552833 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
31028 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
107175 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
491462 usd
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
196500 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
181925 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
82456 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
285433 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
586374 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-507710 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-69595 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
525389 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
191439 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17679 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
121844 usd
DREM Stock Issued During Period Share Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodShareRestrictedStockAwardNetOfForfeitures
4590000 shares
us-gaap Stock Issued1
StockIssued1
91800 usd
CY2009Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
75000000 shares
CY2009Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2009Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2009Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2009Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_ztagXklxAbGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_864_z7MeeL8e7LRh">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62821 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
59671 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3066 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6216 usd
us-gaap Depreciation
Depreciation
3150 usd
us-gaap Depreciation
Depreciation
3387 usd
CY2023Q2 DREM Other Deposits Net
OtherDepositsNet
4657211 usd
CY2022Q4 DREM Other Deposits Net
OtherDepositsNet
3677662 usd
CY2023Q2 DREM Deposits And Costs Coincident To Acquisition Of Land For Development
DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment
7158634 usd
CY2022Q4 DREM Deposits And Costs Coincident To Acquisition Of Land For Development
DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment
6179085 usd
CY2023Q2 us-gaap Loans Payable To Bank
LoansPayableToBank
3407579 usd
CY2022Q4 us-gaap Loans Payable To Bank
LoansPayableToBank
3748579 usd
CY2023Q2 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
1388563 usd
CY2022Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
3113563 usd
CY2023Q2 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
2019016 usd
CY2022Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
635016 usd
CY2023Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.12 pure
us-gaap Interest And Debt Expense
InterestAndDebtExpense
54050 usd
CY2022 us-gaap Interest And Debt Expense
InterestAndDebtExpense
37250 usd
CY2023Q2 us-gaap Other Notes Payable
OtherNotesPayable
552833 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
923660 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
908660 usd

Files In Submission

Name View Source Status
0001493152-23-029420-index-headers.html Edgar Link pending
0001493152-23-029420-index.html Edgar Link pending
0001493152-23-029420.txt Edgar Link pending
0001493152-23-029420-xbrl.zip Edgar Link pending
drem-20230630.xsd Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
drem-20230630_cal.xml Edgar Link unprocessable
drem-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
drem-20230630_pre.xml Edgar Link unprocessable
drem-20230630_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending